Benefit-Cost Analysis Under Threat
The Trump Administration is underweighting the value of human health in benefit-cost analysis.
Valuing the Benefits of Reducing Fine Particles
EPA’s new rule fails to reform the agency’s methods for calculating benefits when regulating particulate matter.
The Case Against Rollback Exceptionalism
OMB’s recent memo fails to make a successful case for deregulation.
Speeding Up the Deregulatory Process
Experts question the legality and wisdom of the Trump Administration’s plan to speed up agencies’ deregulatory efforts.
The Perils and Promise of AI in Regulatory Enforcement
ACUS recommends best practices for AI and algorithmic tools to detect and prosecute regulatory violations.
Challenges of the Chainsaw Approach to Public Sector Automation
The Trump Administration’s mad rush toward AI automation of the administrative state will not succeed.
When Is an Independent Agency Independent?
A new executive order may eliminate the independence of independent regulatory agencies.
Amid the Norm Smashing, Some Durability Remains
President Trump has issued dramatic deregulatory executive orders, but some normalcy remains.
Regulatory Benefit-Cost Analysis Under the Trump Administration
President Trump’s deregulatory push will strain benefit-cost analysis.
Trump Deregulatory Review Redux Plus
Trump’s 1-in-10-out executive order threatens necessary regulations and existing constitutional norms.
Dictatorship and Accountability
A recent Trump executive order unlawfully undermines the authority of independent agencies.
Maintaining the Durability of Regulatory Analysis
Susan Dudley, former OIRA Administrator, discusses proposed changes to federal guidelines for regulatory impact analysis.











